[1] Chauhan N,Calderone R.Two-component signal transduction proteins as potentisl drug targets in medically important fungi[J]. Infect Immun,2008,76(11):4795-4803. [2] Crump JA,Griffin PM,Angulo FJ.Bacterial contamination of animal feed and its relationship to human foodbome illness[J]. Clin Infect Dis,2002,35(7):859-865. [3] Kruppa M,Calderone R.Two-component signal transduction in human fungal pathogens[J]. FEMS Yeast Res,2006,6 (2):149-159. [4] Bahn YS.Master and commander in fungal pathogens:the twocomponent system and the HOG signaling pathway[J]. Eukaryot Cell,2008,7(12):.2017-2036. [5] Saito H,Tatebayashi K.Regulation of the osmoregulatory HOG MAPK cascade in yeast[J]. Biochem,2004,136(3):267-272. [6] Chauhan N,Large JP,Calderone R.Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus[J]. Nat Rev Microbiol,2006,4(6):435-444. [7] Lange R,Wagner C,de Saizieu A.Domain organization and molecular characterization of 13 two-component systems identified by genome sequencing of Streptococcus pneumoniae[J]. Gene,1999,237(1):223-234. [8] Petrikaito V,Tarasevicius E,Pavilonis A.New ethacridine derivatives as the potential antifungal and antibacterial preparations[J]. Medicina(Kaunas),2007,43(8):657-663. [9] Deschenes R J,Lin H,Ault AD.Antifungal properties and target evaluation of three putative bacterial histidine kinase inhibitors[J]. Antimicrob Agents Chemother,1999,43(7):1700-1703. [10] Sangamwar AT,Deshpande UD,Pekamwar SS.Antifungals:need to search for a new molecular target[J]. Indian J Pharm Sci,2008,70(4):423-430. [11] Duo M,Zhang M,Luk YY.Inhibition of Candida albicans growth by brominates furanones[J]. Appl Microbiol Biotechnol,2010,85 (5):1551-1563. [12] Foster JE,Sheng Q,McChin JR.Kinetic and mechanistic analyses of new classes of inhibitors of two-component signal transduction systems using a coupled assay containing HpkADrrA from Thermotogamaritima[J]. Microbiology,2004,150(Pt4):885-896. [13] Sergeev PV,Romanenko IM,Ukhina TV.The cellular acid phosphatase activity in yeast-like fungi of the genus Candida exposed to ultrasound,polyene antibiotics and dyes[J]. Biull Eksp Biol Med,1993,116(9):272-274. [14] Yamada-Okabe T,Mio T,Ono N.Roles of three histidine kinase genes in hyphal development and virulence of the pathogenic fungus Candida albicans[J]. J Bacteriol,1999,181(23):7243-7247. [15] Hilliard JJ,Goldschmidt RM,Licata L.Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems[J]. Antimicrob Agents Chemother,1999,43(7):1693-1699. [16] Stephenson K,Yamaguchi Y,Hoch JA.The mechanism of action of inhibitors of bacterial two-component signal transduction systems[J]. Biological Chemistry,2000,275 (49):38900-38904. [17] Cheng Z,Kumagai Y,Lin M.Intra-leukocyte expression of two-component systems in Ehrlichia chaffeensis and Anaplasma phagocytophilum and effects of the histidine kinase inhibitor closantel[J]. Cell Microbiol,2006,8 (8):1241-1252. [18] Theodorou EC,Theodorou MC,Kyriakidis DA.Inhibition of the signal transduction through the AtoSC system by histidine kinase inhibitors inEscherichia coli[J]. Cell Signal,2011,23(8):1327-1337. [19] Hlasta DJ,Demers JP,Foleno BD.Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity:pharmacophore identification based on the screening hit closantel[J]. Bioorg Med Chem Lett,1998,8(14):1923-1928. [20] Calera JA,Zhao XJ,Calderone R.Defective hyphal development and avirulence caused by a deletion of the SSKl response regulator gene in C.albicans[J]. Infect Immun,2000,68(2):518-525. [21] Tabbene O,Kalai L,Ben Slimene I.Anti-candida effect of bacillomycin D-like lipopeptides from Bacillus subtilis B38[J]. FEMS Microbiol Lett,2011,316(2):108-114. [22] Ganendren R,Widmer F,Singhal V.In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans[J]. Antimicrob Agents Chemother,2004,48(5):1561-1569. [23] Cheetham J,Smith DA,da Silva Dantas A.A single MAPKKK regulates the Hogl MAPK pathway in the pathogenic fungus C.albicans[J]. Mol Biol Cell,2007,18(11):4603-4614. [24] Stephenson K,Hoch JA.Two-component and phosphorelay signal-transduction systems as therapeutic targets[J]. Curr Opin Pharmacol,2002,2(5):507-512. |